(Date:11/23/2009)... communication, computation and more powerful ways...se quantum states as carriers of information is an...ave shown, mathematically, how to gently tease out...eping the information intact. Their work is report...s and highlighted with a Viewpoint in Physics (...
(Date:11/23/2009)...wswire-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: ...er27,2009astheex-dividenddateforits$200millionspec...ationtransactioncompletedonNovember2,2009.Thedivid...ecordontherecorddate,December1,2009.NASDAQhassetth...hareofcommonstockforpurposesoftheex-dividenddateon...
(Date:11/23/2009)...-FirstCall/--NeogenCorporation(Nasdaq: NEOG )annou...ogen,sBoardofDirectorsatthecompany,srecentannualme...rsofexperienceinthefood,agriculture,andtradeindust...lturaleconomicsatVirginiaTechUniversity.FromJanuar...ulturenegotiatorwiththerankofambassador. ,, "Si...
(Date:11/23/2009)...uneDesignC or p.(IDC)announcedtodaythatDr.BruceL.A...sasuccessfultrackrec or dinbiotechnologyexecutivem...ymoGenetics,inSeattle,WAandChiefScientificOfficera...ttp://www.newscom.com/cgi-bin/prnh/20091123/SF1522...iveOfficercommented,"IamdelightedtowelcomeDr.Bruce...
Breaking Biology Technology:PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Richard T. Crowder Joins Neogen's Board of Directors 2Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2...ocus on Late-Stage and Marketed ...nd OXFORD, England, May 1 ,EUSA Pharma Inc (,EUSA,...y,focused on oncology, pain control and critical c...clonal antibody research business to the French,co...rently, EUSA has,divested its recombinant L-aspara...
...sdaq:,VICL) today announced that the company will ...ch 31, 2008, before the opening of trading on,Thur...cast to discuss the,financial results and provide ... May 8. The call is open on a listen-only basis to...details on independent and partnered,development p...
...:,FVRL), a biopharmaceutical company developing pa...atment of cancer, announced today that it will,hos...Eastern Time on,Thursday, May 8, 2008 to discuss t... A press release will be issued after the U.S. sto...wscom.com/cgi-bin/prnh/20080404/LAF521LOGO ), A l...
Other Biology Technology:EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product 2EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product 3Vical Announces News Release and Conference Call Schedule for First Quarter 2008 Financial Results 2Favrille to Host Conference Call and Live Webcast to Discuss First Quarter 2008 Financial Results on May 8, 2008 2Rat Anti-Mouse Endoglin Monoclonal Antibody, Fluorescein Conjugated, Clone 209701 from R&D Systems
Goat Anti-Rat CNTF R alpha Polyclonal Antibody, Unconjugated from R&D Systems
Rat Anti-Human MFRP Monoclonal Antibody, Unconjugated, Clone 291218 from R&D Systems
Goat Anti-Human RELT / TNFRSF19L Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: